GSK to raise $1B by selling partial stake in former consumer health unit Haleon

As GSK's former consumer health unit Haleon nears its one-year mark of independent operations, its former parent company is shedding 240 million shares.

Since Haleon’s July 2022 demerger, GSK has kept a 12.94% stake in the consumer health company. But in a statement this week, GSK said it's selling 240 million shares, or a 2.5% stake, in the company. The company plans to sell the shares to institutional investors at an undisclosed price.